StockData
Scinai Immunotherapeutics Ltd. logo

Scinai Immunotherapeutics Ltd. (SCNI) stock

SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.75−0.00 (-0.32%)

Close on Oct 19, 2026Market cap –P/E –Yield –

Scinai Immunotherapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$8.31M, down 273.2% from the year before. The highest annual figure on record is $4.80M in fiscal 2024.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$8.31M-273.2%
FY2024Dec 31, 2024$4.80M–
FY2023Dec 31, 2023-$6.50M–
FY2022Dec 31, 2022-$5.80M–
FY2021Dec 31, 2021-$8.21M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2023Jun 30, 2023-$3.76M–
Q1 FY2023Mar 31, 2023-$3.52M–
Q2 FY2022Jun 30, 2022-$2.98M–
Q1 FY2022Mar 31, 2022-$2.48M–

More Scinai Immunotherapeutics figures

See a number that looks wrong?